デフォルト表紙
市場調査レポート
商品コード
1789390

造影剤市場:種類別、画像技術別、用途別、投与経路別、エンドユーザー別、地域別

Contrast Media Market, By Type, By Imaging Technique, By Application, By Route of Administration, By End User, By Geography


出版日
ページ情報
英文 165 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
造影剤市場:種類別、画像技術別、用途別、投与経路別、エンドユーザー別、地域別
出版日: 2025年07月31日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

造影剤市場は2025年に63億5,000万米ドルと推定され、2032年には109億5,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率(CAGR)は8.1%で成長すると予測されます。

分析範囲 分析詳細
基準年 2024年 市場規模 (2025年) 63億5,000万米ドル
実績データ 2020~2024年 予測期間 2025~2032年
予測期間のCAGR (2025~2032年) 8.10% 予測金額 (2032年) 109億5,000万米ドル

世界の造影剤市場は、より広範な医療画像産業における重要なセグメントであり、画像診断の際に体内構造の可視性を高めるために設計された特殊な薬剤を包含しています。これらの造影剤は造影色素としても知られ、CT(コンピュータ断層撮影)、MRI(磁気共鳴画像法)、超音波検査、X線検査など様々な画像診断を受ける患者に投与され、診断精度と臨床転帰を向上させます。

同市場には、ヨウ素系造影剤、ガドリニウム系造影剤、バリウム系化合物、マイクロバブル造影剤などさまざまな種類の造影剤があり、それぞれが特定の画像診断用途や患者の要求に合わせて調整されています。慢性疾患の増加、人口の高齢化、医療用画像診断機器の技術進歩に伴い、高度な造影剤ソリューションの需要は世界的に拡大し続けています。同市場は、副作用を最小限に抑えつつ診断精度を向上させたいというニーズに後押しされ、製剤化学、安全性プロファイル、標的画像用途における絶え間ない技術革新が特徴となっています。市場参入企業は、生体適合性の向上、腎毒性の低減、画像処理能力の強化を実現した次世代造影剤の開発に注力し、世界中の多様な医療環境における臨床上の要求や規制基準の進化に対応しています。

市場力学

世界の造影剤市場の成長は、国際的な医療システムにおける持続的な成長軌道を後押しするいくつかの主要な要因によって牽引されています。心血管疾患、がん、神経疾患の罹患率の増加により、高度な画像診断が必要となり、解剖学的構造や病態の正確な可視化を可能にする高品質の造影剤への需要が高まっています。高解像度CTスキャナー、高度MRIシステム、高性能超音波装置の開発など、医療用画像診断機器の技術的進歩は、画像診断能力の向上を活用できる造影剤製剤の強化の機会を生み出しています。

世界人口の高齢化は、慢性疾患管理や予防医療・スクリーニングプログラムのために、高齢患者がより頻繁な画像診断を必要とするため、大きな成長促進要因となっています。しかし、市場は、特に大規模な臨床試験と安全性評価を必要とする新規造影剤製剤の場合、製品上市を遅らせ、開発コストを増大させる厳しい規制承認プロセスなどの顕著な抑制要因に直面しています。特定の造影剤に関連する造影剤誘発性腎症、アレルギー反応、腎原性全身性線維症に関する安全性の懸念は、医療従事者や患者の慎重な採用パターンにつながり、市場拡大の課題となっています。こうした制約がある一方で、新興経済諸国における医療インフラの拡大、医療費の増加、疾患の早期発見に対する意識の高まり、標的画像ソリューションを提供する臓器特異的造影剤の開発などから、大きなビジネスチャンスが生まれています。

当レポートの主な特徴

  • 当レポートは、世界の造影剤市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模・CAGRを掲載しています。
  • また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の造影剤市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
  • 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
  • 「世界の造影剤市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
  • 利害関係者は、世界の造影剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学・規制・動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • ポーターのファイブフォース分析
  • 企業合併・買収 (M&A) のシナリオ
  • 業界動向

第4章 世界の造影剤市場:種類別(金額ベース、2020~2032年)

  • ヨウ素系造影剤
  • モノマー型ヨウ素系造影剤
  • 二量体ヨウ素系造影剤
  • ガドリニウム系造影剤(GBCM)
  • バリウム系造影剤
  • その他(マイクロバブル造影剤)

第5章 世界の造影剤市場:画像技術別(金額ベース、2020~2032年)

  • X線/コンピュータ断層撮影(CT)
  • 磁気共鳴画像法(MRI)
  • 超音波画像診断
  • 透視検査
  • その他(血管造影)

第6章 世界の造影剤市場:用途別(金額ベース、2020~2032年)

  • 心血管系
  • 腫瘍学
  • 神経学
  • 胃腸
  • 筋骨格
  • 泌尿器科
  • 感染症
  • その他の治療領域

第7章 世界の造影剤市場:投与経路別(金額ベース、2020~2032年)

  • 経口
  • 直腸
  • 静脈内

第8章 世界の造影剤市場:エンドユーザー別(金額ベース、2020~2032年)

  • 病院
  • 診断センター
  • 画像センター
  • 外来手術センター
  • その他(研究・学術機関)

第9章 世界の造影剤市場:地域別(金額ベース、2020~2032年)

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第10章 競合情勢

  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN(Medtronic)
  • Esaote S.p.A.
  • Shimadzu Corporation
  • Hughes Medical Systems

第11章 アナリストの提言

  • 「運命の輪」
  • アナリストの見解
  • Coherent Opportunity Map (COM)

第12章 参考文献と調査手法

  • 参考文献
  • 分析手法
  • Coherent Market Insightsについて
目次
Product Code: CMI8350

Contrast Media Market is estimated to be valued at USD 6.35 Bn in 2025 and is expected to reach USD 10.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.35 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.10% 2032 Value Projection: USD 10.95 Bn

The global contrast media market represents a critical segment within the broader medical imaging industry, encompassing specialized pharmaceutical agents designed to enhance the visibility of internal body structures during diagnostic imaging procedures. These contrast agents, also known as contrast materials or contrast dyes, are administered to patients undergoing various imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray examinations to improve diagnostic accuracy and clinical outcomes.

The market comprises different types of contrast media, including iodinated contrast agents, gadolinium-based contrast agents, barium-based compounds, and microbubble contrast agents, each tailored for specific imaging applications and patient requirements. With the increasing prevalence of chronic diseases, aging population demographics, and technological advancements in medical imaging equipment, the demand for sophisticated contrast media solutions continues to expand globally. The market is characterized by continuous innovation in formulation chemistry, safety profiles, and targeted imaging applications, driven by the need for enhanced diagnostic precision while minimizing adverse reactions. Key market participants focus on developing next-generation contrast agents with improved biocompatibility, reduced nephrotoxicity, and enhanced imaging capabilities to meet evolving clinical demands and regulatory standards across diverse healthcare settings worldwide.

Market Dynamics

The global contrast media market growth is primarily driven by several key factors that collectively fuel its sustained growth trajectory across international healthcare systems. The increasing incidence of cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic imaging procedures, thereby boosting demand for high-quality contrast agents that enable precise visualization of anatomical structures and pathological conditions. Technological advancements in medical imaging equipment, including the development of high-resolution CT scanners, advanced MRI systems, and sophisticated ultrasound devices, create opportunities for enhanced contrast media formulations that can capitalize on improved imaging capabilities.

The aging global population represents a significant growth driver, as elderly patients require more frequent diagnostic imaging procedures for chronic disease management and preventive healthcare screening programs. However, the market faces notable restraints including stringent regulatory approval processes that can delay product launches and increase development costs, particularly for novel contrast agent formulations requiring extensive clinical trials and safety evaluations. Safety concerns related to contrast-induced nephropathy, allergic reactions, and nephrogenic systemic fibrosis associated with certain contrast agents pose challenges for market expansion, leading to cautious adoption patterns among healthcare providers and patients. Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, growing awareness about early disease detection, and the development of organ-specific contrast agents that offer targeted imaging solutions.

Key Features of the Study

  • This report provides an in-depth analysis of the global contrast media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global contrast media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Bayer AG, Bracco Imaging, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, Guerbet Group, Mallinckrodt Pharmaceuticals, Canon Medical Systems, Hologic, Inc., Lantheus Medical Imaging, COVIDIEN (Medtronic), Esaote S.p.A., Shimadzu Corporation, and Hughes Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contrast media market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Iodinated Contrast Media
    • Monomeric Iodinated Contrast Media
    • Dimeric Iodinated Contrast Media
    • Gadolinium-Based Contrast Media (GBCM)
    • Barium-Based Contrast Media
    • Others (Microbubble Contrast Media)
  • Imaging Technique Insights (Revenue, USD Bn, 2020 - 2032)
    • X-ray/Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound Imaging
    • Fluoroscopy
    • Others (Angiography)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cardiovascular
    • Oncology
    • Neurology
    • Gastrointestinal
    • Musculoskeletal
    • Pulmonary
    • Urology
    • Infectious Diseases
    • Other Therapeutic Areas
  • Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Rectal
    • Intravenous
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Imaging Centers
    • Ambulatory Surgical Centers
    • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Bayer AG
    • Bracco Imaging
    • Siemens Healthineers
    • Fujifilm Holdings Corporation
    • Philips Healthcare
    • Guerbet Group
    • Mallinckrodt Pharmaceuticals
    • Canon Medical Systems
    • Hologic, Inc.
    • Lantheus Medical Imaging
    • COVIDIEN (Medtronic)
    • Esaote S.p.A.
    • Shimadzu Corporation
    • Hughes Medical Systems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contrast Media Market, By Type
    • Global Contrast Media Market, By Imaging Technique
    • Global Contrast Media Market, By Application
    • Global Contrast Media Market, By Route of Administration
    • Global Contrast Media Market, By End User
    • Global Contrast Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contrast Media Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Monomeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dimeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gadolinium-Based Contrast Media (GBCM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Barium-Based Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Microbubble Contrast Media)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contrast Media Market, By Imaging Technique, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • X-ray/Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ultrasound Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fluoroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Angiography)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contrast Media Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contrast Media Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Contrast Media Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Contrast Media Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bracco Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Guerbet Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • COVIDIEN (Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Esaote S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hughes Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us